LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9334-4 | Methanol | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Methanol [Mass/volume] in Blood | Methanol Bld-mCnc | null | ACTIVE | 1.0i | 2.73 |
93344-0 | Treatment to which genetic variant confers resistance | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal | Variant assoc therapy resist | null | ACTIVE | 2.67 | 2.67 |
93345-7 | Genetic variant effect on drug resistance | Find | Pt | Bld/Tiss | Nar | null | MOLPATH | 1 | Genetic variant effect on drug resistance in Blood or Tissue Narrative | Variant drug resist effect Nar | null | ACTIVE | 2.67 | 2.67 |
93346-5 | Genetic variant effect on drug sensitivity | Find | Pt | Bld/Tiss | Nar | null | MOLPATH | 1 | Genetic variant effect on drug sensitivity in Blood or Tissue Narrative | Variant drug sens effect Nar | null | ACTIVE | 2.67 | 2.67 |
93347-3 | Available treatment related to genetic variant and not to patient diagnosis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal | Avail tx for variant but not dx Bld/T | null | ACTIVE | 2.67 | 2.67 |
93348-1 | Available treatment related to genetic variant and to patient diagnosis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal | Avail tx for variant+dx Bld/T | null | ACTIVE | 2.67 | 2.67 |
93349-9 | Treatment to which interaction between genetic variants confers resistance | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal | Variant interaction assoc therapy resist | null | ACTIVE | 2.67 | 2.67 |
93350-7 | Monocytes.HLA-DR/100 Monocytes | NFr | Pt | Bld | Qn | Flow cytometry | CELLMARK | 1 | Monocytes.HLA-DR/100 Monocytes in Blood by Flow cytometry (FC) | Mono.HLA-DR/100 Mono NFr Bld FC | null | ACTIVE | 2.67 | 2.67 |
9335-1 | Appearance | Aper | Pt | Body fld | Nom | null | SPEC | 1 | Appearance of Body fluid | Appearance Fld | null | ACTIVE | 1.0i | 2.73 |
93351-5 | HLA-DR Ag | EntNum | Pt | Monocyte | Qn | Flow cytometry | CELLMARK | 1 | HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) | HLA-DR Ag EntNum Mono FC | null | ACTIVE | 2.67 | 2.67 |
93352-3 | Neutrophils.CD64/100 Neutrophils | NFr | Pt | Bld | Qn | Flow cytometry | CELLMARK | 1 | Neutrophils.CD64/100 Neutrophils in Blood by Flow cytometry (FC) | Neut.CD64/100 Neut NFr Bld FC | null | ACTIVE | 2.67 | 2.67 |
93353-1 | CD64 Ag | EntNum | Pt | Neutrophil | Qn | Flow cytometry | CELLMARK | 1 | CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC) | CD64 Ag EntNum Neut FC | null | ACTIVE | 2.67 | 2.67 |
93354-9 | Neutrophil CD64 & Monocyte HLA DR panel | - | Pt | Bld | Qn | Flow cytometry | PANEL.CELLMARK | 1 | Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) | Neut CD64 + Mono HLA DR Pnl Bld FC | null | ACTIVE | 2.67 | 2.67 |
93356-4 | Cells.cytogenetic abnormality | Num | Pt | Bld/Tiss | Qn | Molgen | MOLPATH | 1 | Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method | Cells w cytogenetic abnl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93357-2 | Monotypic plasma cell identification & risk stratification panel | - | Pt | Bone mar | - | Molgen | PANEL.MOLPATH | 1 | Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method | Mono PC ID + risk Pnl Mar | null | ACTIVE | 2.67 | 2.67 |
93358-0 | Plasma cells.polyclonal/Cells counted | NFr | Pt | Bone mar | Qn | Flow cytometry | HEM/BC | 1 | Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) | Polyclonal PCs/Cells NFr Mar FC | null | ACTIVE | 2.67 | 2.67 |
93359-8 | Monotypic plasma cell DNA ploidy | Type | Pt | Bone mar | Nom | Flow cytometry | MOLPATH | 1 | Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) | Monotypic PC DNA ploidy Mar FC | null | ACTIVE | 2.67 | 2.67 |
93360-6 | Monotypic plasma cell DNA index | Ratio | Pt | Bone mar | Qn | Flow cytometry | MOLPATH | 1 | Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) | Monotypic PC DNA index Mar FC-Rto | null | ACTIVE | 2.67 | 2.67 |
93361-4 | Plasma cells.monotypic.S phase/100 cells | NFr | Pt | Bone mar | Qn | Flow cytometry | MOLPATH | 1 | Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC) | Mono PC in S Phs NFr Mar FC | null | ACTIVE | 2.67 | 2.67 |
93362-2 | Plasma cells.monotypic population | Prid | Pt | Bone mar | Nom | Flow cytometry | HEM/BC | 1 | Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) | Monotypic plasma cells Mar FC | null | ACTIVE | 2.67 | 2.67 |
93363-0 | Plasma cell DNA content & proliferation panel | - | Pt | Bone mar | - | Flow cytometry | PANEL.HEM/BC | 1 | Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) | PC DNA content + prolif Pnl Mar FC | null | ACTIVE | 2.67 | 2.67 |
93364-8 | Genetic variant diagnostic significance | Imp | Pt | Bld/Tiss | Nar | null | MOLPATH | 1 | Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative | Genetic variant diag sig Bld/T-Imp | null | ACTIVE | 2.67 | 2.67 |
93365-5 | Genetic variant prognostic significance | Imp | Pt | Bld/Tiss | Nar | null | MOLPATH | 1 | Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative | Genetic variant prog sig Bld/T-Imp | null | ACTIVE | 2.67 | 2.67 |
93366-3 | Gene studied with no variant found | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Gene studied with no variant found [Identifier] in Blood or Tissue Nominal | Gene studied w no variant found Bld/T | null | ACTIVE | 2.67 | 2.67 |
93367-1 | Variant of unknown significance | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH | 1 | Variant of unknown significance [Identifier] in Blood or Tissue Nominal | Variant unknown sig Bld/T | null | ACTIVE | 2.67 | 2.67 |
93368-9 | Summary of interaction between genetic variants | Imp | Pt | Bld/Tiss | Nar | null | MOLPATH | 1 | Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative | Variant interaction summary Bld/T-Imp | null | ACTIVE | 2.67 | 2.67 |
9336-9 | IgA subclass 1/IgA.total | MFr | Pt | Ser | Qn | null | CHEM | 1 | IgA subclass 1/IgA.total in Serum | IgA1 MFr Ser | null | ACTIVE | 1.0i | 2.73 |
93369-7 | Krebs von den Lungen-6 | ACnc | Pt | Ser/Plas | Qn | IA | CHEM | 1 | Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay | KL-6 SerPl IA-aCnc | null | ACTIVE | 2.67 | 2.67 |
93370-5 | Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel | - | Pt | Ser | - | null | PANEL.MICRO | 1 | Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum | A phagocyt + E chaff IgG + IgM Pnl Ser | null | ACTIVE | 2.67 | 2.67 |
93371-3 | von Willebrand factor cleaving protease activity | CCnc | Pt | PPP | Qn | Chromo | COAG | 1 | von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method | vWF Cp Act PPP Chro-cCnc | null | ACTIVE | 2.67 | 2.68 |
93372-1 | Indexing - national clinical trial number | - | - | ^FDA product label | Nar | null | DOCUMENT.REGULATORY | 2 | FDA product label Indexing - national clinical trial number | FDA label Indexing - NCT # | null | ACTIVE | 2.67 | 2.67 |
93373-9 | Columbia - suicide severity rating scale screener - recent | - | Pt | ^Patient | - | C-SSRS | PANEL.SURVEY.CSSRS | 4 | Columbia - suicide severity rating scale screener - recent [C-SSRS] | null | © 2011 Dr. Kelly Posner, first author of the scale. Used with permission | ACTIVE | 2.67 | 2.67 |
93374-7 | Suicide risk level | Find | Pt | ^Patient | Ord | null | SURVEY.CSSRS | 4 | Suicide risk level | null | null | ACTIVE | 2.67 | 2.7 |
9337-7 | IgA subclass 1/IgA.total | MFr | Pt | Ser | Qn | null | CHEM | 1 | Deprecated IgA subclass 1/IgA.total in Serum | Deprecated IgA1 Fr Ser | null | DEPRECATED | 1.0i | 2.46 |
93384-6 | Serratia sp DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Serratia sp DNA [Presence] by NAA with probe detection in Positive blood culture | Serratia sp DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
9338-5 | Rheumatoid factor.IgM | ACnc | Pt | Ser | Qn | IA | SERO | 1 | Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay | RF IgM Ser IA-aCnc | null | ACTIVE | 1.0i | 2.73 |
93385-3 | Salmonella sp DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Salmonella sp DNA [Presence] by NAA with probe detection in Positive blood culture | Salmonella DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93386-1 | Pseudomonas aeruginosa DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Pseudomonas aeruginosa DNA [Presence] by NAA with probe detection in Positive blood culture | P aeruginosa DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93387-9 | Proteus mirabilis DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Proteus mirabilis DNA [Presence] by NAA with probe detection in Positive blood culture | P mirabilis DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93388-7 | Neisseria meningitidis DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Neisseria meningitidis DNA [Presence] by NAA with probe detection in Positive blood culture | N men DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93389-5 | Gram positive bacteria DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Gram positive bacteria DNA [Presence] by NAA with probe detection in Positive blood culture | GP bact DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93390-3 | Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes | PrThr | Pt | Isolate/Specimen | Ord | Molgen | MICRO | 1 | Carbapenem resistance blaOXA-23-like+blaOXA-48-like genes [Presence] in Isolate or Specimen by Molecular method | blaOXA-23+48-like genes Islt/Spm Ql | null | ACTIVE | 2.67 | 2.7 |
93391-1 | Stenotrophomonas maltophilia DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Stenotrophomonas maltophilia DNA [Presence] by NAA with probe detection in Positive blood culture | S maltophilia DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93392-9 | Serratia marcescens DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Serratia marcescens DNA [Presence] by NAA with probe detection in Positive blood culture | S marcescens DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
9339-3 | Insulin^6H post 75 g glucose PO | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Insulin [Mass/volume] in Serum or Plasma --6 hours post 75 g glucose PO | Insulin 6h p 75 g Glc PO SerPl-mCnc | null | ACTIVE | 1.0i | 2.73 |
93393-7 | Proteus sp DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Proteus sp DNA [Presence] by NAA with probe detection in Positive blood culture | Proteus sp DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93394-5 | Morganella morganii DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Morganella morganii DNA [Presence] by NAA with probe detection in Positive blood culture | M. morganii DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93395-2 | Klebsiella pneumoniae DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Klebsiella pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture | K pneumon DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93396-0 | Fusobacterium nucleatum DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Fusobacterium nucleatum DNA [Presence] by NAA with probe detection in Positive blood culture | F. nucleatum DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93397-8 | Haemophilus influenzae DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Haemophilus influenzae DNA [Presence] by NAA with probe detection in Positive blood culture | Haem influ DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93398-6 | Klebsiella oxytoca DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Klebsiella oxytoca DNA [Presence] by NAA with probe detection in Positive blood culture | K oxytoca DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93399-4 | Fusobacterium necrophorum DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Fusobacterium necrophorum DNA [Presence] by NAA with probe detection in Positive blood culture | F. necrophorum DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
934-0 | Blood product unit ID | Num | Pt | Dose | Qn | null | BLDBK | 1 | Blood product unit ID [#] | BPU ID | null | ACTIVE | 1.0 | 2.73 |
93400-0 | Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA [Presence] by NAA with probe detection in Positive blood culture | E. aerog+amn+gergo DNA Bld Pos Ql NAA+pr | null | ACTIVE | 2.67 | 2.67 |
9340-1 | Apolipoprotein B/Apolipoprotein A-I | Prctl | Pt | Ser/Plas | Qn | null | CHEM | 1 | Apolipoprotein B/Apolipoprotein A-I [Percentile] | Apo B/Apo A-I Prctl SerPl | null | ACTIVE | 1.0i | 2.73 |
93401-8 | Escherichia coli DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Escherichia coli DNA [Presence] by NAA with probe detection in Positive blood culture | E coli DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93402-6 | Cronobacter sakazakii DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture | C sakazakii DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93403-4 | Citrobacter sp DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture | Citrobac sp DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93404-2 | Enterobacter cloacae complex DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture | E cloac comp DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93405-9 | Bacteroides fragilis DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture | B fragilis DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93406-7 | Acinetobacter baumannii DNA | PrThr | Pt | Bld.pos growth | Ord | Probe.amp.tar | MICRO | 1 | Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture | A baumannii DNA Bld Pos Ql NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93407-5 | Gram negative blood culture panel | - | Pt | Bld.pos growth | - | Probe.amp.tar | PANEL.MICRO | 1 | Gram negative blood culture panel by NAA with probe detection in Positive blood culture | GN Bld Culture Pnl Bld Pos NAA+probe | null | ACTIVE | 2.67 | 2.67 |
93408-3 | Platelet aggregation.epinephrine induced^10 umol/L | RelACnc | Pt | PRP | Qn | null | COAG | 1 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L | PA Epineph 10 umol/L PRP | null | ACTIVE | 2.67 | 2.67 |
93409-1 | Platelet aggregation.epinephrine induced^5 umol/L | RelACnc | Pt | PRP | Qn | null | COAG | 1 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L | PA Epineph 5 umol/L PRP | null | ACTIVE | 2.67 | 2.67 |
93410-9 | Platelet aggregation.ristocetin induced^5 ug/mL | RelACnc | Pt | PRP | Qn | null | COAG | 1 | Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL | PA Rist 5 ug/mL PRP | null | ACTIVE | 2.67 | 2.67 |
93411-7 | COMT gene product metabolic activity interpretation | Imp | Pt | Bld/Tiss | Ord | Molgen | MOLPATH.PHARMG | 1 | COMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | COMT gene prod met activ Bld/T-Imp | null | ACTIVE | 2.67 | 2.68 |
93412-5 | SLCO1B1 gene targeted mutation analysis | Find | Pt | Bld/Tiss | Doc | Molgen | MOLPATH.PHARMG | 1 | SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | SLCO1B1 Mut Anl Bld/T | null | ACTIVE | 2.67 | 2.67 |
93413-3 | Mechanical circulatory support+consultation note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | Mechanical circulatory support Consultation note | MCS+consult note | null | TRIAL | 2.67 | 2.67 |
93414-1 | Altered level of consciousness in last 3D | Find | 3D | ^Patient | Ord | CAM.CMS | SURVEY.CMS | 4 | Altered level of consciousness in last 3 day [CAM.CMS] | null | null | ACTIVE | 2.68 | 2.68 |
93415-8 | Disorganized thinking in last 3D | Find | 3D | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Deprecated Disorganized thinking in last 3 days [CMS Assessment] | null | null | DEPRECATED | 2.67 | 2.7 |
93416-6 | Inattention in last 3D | Find | 3D | ^Patient | Nom | CMS Assessment | SURVEY.CMS | 4 | Deprecated Inattention in last 3 days [CMS Assessment] | null | null | DEPRECATED | 2.67 | 2.7 |
93417-4 | IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) | - | 3D | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) [CMS Assessment] | null | null | DISCOURAGED | 2.67 | 2.69 |
93418-2 | (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript | PrThr | Pt | Tiss | Ord | Molgen | MOLPATH | 1 | (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method | (8;8)(HEY1,NCOA2) Tiss Ql | null | ACTIVE | 2.67 | 2.67 |
9341-9 | Cerebroside sulfatase | MRat | 24H | Urine | Qn | null | CHEM | 1 | Cerebroside sulfatase [Mass/time] in 24 hour Urine | Arylsulfatase A 24h Ur-mRate | null | ACTIVE | 1.0i | 2.7 |
93419-0 | Alpha 1 antitrypsin fecal clearance panel | - | Pt | Ser/Plas+Stool | Qn | null | PANEL.CHEM | 1 | Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool | A1AT Cl Pnl SerPl+Stl | null | ACTIVE | 2.67 | 2.67 |
93420-8 | APOA1 gene full mutation analysis | Find | Pt | Bld/Tiss | Doc | Sequencing | MOLPATH | 1 | APOA1 gene full mutation analysis in Blood or Tissue by Sequencing | APOA1 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.67 | 2.67 |
93421-6 | Glial fibrillary acidic protein.alpha subunit Ab.IgG | Titr | Pt | CSF | Qn | IF | SERO | 1 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | GFAP alpha IgG Titr CSF IF | null | ACTIVE | 2.67 | 2.68 |
93422-4 | Glial fibrillary acidic protein.alpha subunit Ab.IgG | PrThr | Pt | CSF | Ord | CBA IFA | SERO | 1 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | GFAP alpha IgG CSF Ql CBA IFA | null | ACTIVE | 2.67 | 2.69 |
93423-2 | Glial fibrillary acidic protein.alpha subunit Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Serum by Immunofluorescence | GFAP alpha IgG Titr Ser IF | null | ACTIVE | 2.67 | 2.68 |
93424-0 | Glial fibrillary acidic protein.alpha subunit Ab.IgG | PrThr | Pt | Ser | Ord | CBA IFA | SERO | 1 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | GFAP alpha IgG Ser Ql CBA IFA | null | ACTIVE | 2.67 | 2.69 |
93425-7 | Gamma aminobutyrate B receptor Ab.IgG | Titr | Pt | CSF | Qn | IF | SERO | 1 | GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | GABABR IgG Titr CSF IF | null | ACTIVE | 2.67 | 2.67 |
93426-5 | Gamma aminobutyrate B receptor Ab.IgG | PrThr | Pt | CSF | Ord | CBA IFA | SERO | 1 | GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | GABABR IgG CSF Ql CBA IFA | null | ACTIVE | 2.67 | 2.69 |
9342-7 | Cholesterol | Prctl | Pt | Ser/Plas | Qn | null | CHEM | 1 | Cholesterol [Percentile] | Cholest Prctl SerPl | null | ACTIVE | 1.0i | 2.73 |
93427-3 | Gamma aminobutyrate B receptor Ab.IgG | Titr | Pt | Ser/Plas | Qn | IF | SERO | 1 | GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | GABABR IgG Titr SerPl IF | null | ACTIVE | 2.67 | 2.67 |
93428-1 | Gamma aminobutyrate B receptor Ab.IgG | PrThr | Pt | Ser/Plas | Ord | CBA IFA | SERO | 1 | GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | GABABR IgG SerPl Ql CBA IFA | null | ACTIVE | 2.67 | 2.69 |
93429-9 | Blastomyces sp Ag | MCnc | Pt | Urine | Qn | IA | MICRO | 1 | Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay | Blastomyces Ag Ur IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93430-7 | Blastomyces sp Ag | MCnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay | Blastomyces Ag SerPl IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93431-5 | Blastomyces sp Ag | MCnc | Pt | CSF | Qn | IA | MICRO | 1 | Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | Blastomyces Ag CSF IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93432-3 | Blastomyces sp Ag | MCnc | Pt | BAL | Qn | IA | MICRO | 1 | Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay | Blastomyces Ag BAL IA-mCnc | null | ACTIVE | 2.67 | 2.67 |
93433-1 | Busulfan^4H post busulfan infusion completion | MCnc | Pt | Plas | Qn | null | DRUG/TOX | 1 | Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion | Busulfan 4h p busulfan Plas-mCnc | null | ACTIVE | 2.67 | 2.67 |
93434-9 | Busulfan^2H post busulfan infusion completion | MCnc | Pt | Plas | Qn | null | DRUG/TOX | 1 | Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion | Busulfan 2h p busulfan Plas-mCnc | null | ACTIVE | 2.67 | 2.67 |
9343-5 | Coproporphyrin 1 | MCnc | Pt | Urine | Qn | null | CHEM | 1 | Coproporphyrin 1 [Mass/volume] in Urine | Copro1 Ur-mCnc | null | ACTIVE | 1.0i | 2.73 |
93435-6 | Busulfan^1H post busulfan infusion completion | MCnc | Pt | Plas | Qn | null | DRUG/TOX | 1 | Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion | Busulfan 1h p busulfan Plas-mCnc | null | ACTIVE | 2.67 | 2.67 |
93436-4 | Busulfan^immediately post busulfan infusion completion | MCnc | Pt | Plas | Qn | null | DRUG/TOX | 1 | Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion | Busulfan immed p busulfan Plas-mCnc | null | ACTIVE | 2.67 | 2.67 |
93437-2 | Lurasidone | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Lurasidone [Mass/volume] in Serum or Plasma | Lurasidone SerPl-mCnc | null | ACTIVE | 2.67 | 2.67 |
93438-0 | Herpes Simplex Virus 2 DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | MICRO | 1 | Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection | HSV2 DNA Bld Ql NAA+non-probe | null | ACTIVE | 2.67 | 2.67 |
93439-8 | Herpes Simplex Virus 1 DNA | PrThr | Pt | Bld | Ord | Non-probe.amp.tar | MICRO | 1 | Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection | HSV1 DNA Bld Ql NAA+non-probe | null | ACTIVE | 2.67 | 2.67 |
93440-6 | Herpes Simplex Virus 1 & 2 DNA Panel | - | Pt | Bld | - | Non-probe.amp.tar | PANEL.MICRO | 1 | Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with non-probe detection | HSV 1+2 DNA Pnl Bld NAA+non-probe | null | ACTIVE | 2.67 | 2.67 |
93441-4 | Home accessibility modification date | Date | Pt | ^Patient | Qn | null | CLIN | 2 | Home accessibility modification date | Home access mod date | null | ACTIVE | 2.67 | 2.67 |
93442-2 | Advance directive document format | Find | Pt | ^Patient | Nom | null | CLIN | 2 | Advance directive document format | Advance directive document format | null | ACTIVE | 2.67 | 2.67 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.